Patents by Inventor Shui-Wan Chan

Shui-Wan Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130164733
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Application
    Filed: July 13, 2012
    Publication date: June 27, 2013
    Applicant: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
  • Patent number: 7976849
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: July 12, 2011
    Assignee: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
  • Patent number: 7709006
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: May 4, 2010
    Assignee: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
  • Publication number: 20070128221
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Application
    Filed: January 12, 2007
    Publication date: June 7, 2007
    Applicant: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Yap
  • Patent number: 7179470
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: February 20, 2007
    Assignee: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
  • Publication number: 20030198946
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Application
    Filed: March 25, 2003
    Publication date: October 23, 2003
    Applicant: COMMON SERVICES AGENCY
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
  • Patent number: 6591348
    Abstract: A distributed system structure for a large-way, symmetric multiprocessor system using a bus-based cache-coherence protocol is provided. The distributed system structure contains an address switch, multiple memory subsystems, and multiple master devices, either processors, I/O agents, or coherent memory adapters, organized into a set of nodes supported by a node controller. The node controller receives commands from a master device, communicates with a master device as another master device or as a slave device, and queues commands received from a master device. The node controller has a deterministic delay between latching a snooped command broadcast by the address switch and presenting the command to the master devices on the node controller's master device buses.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: July 8, 2003
    Assignee: International Business Machines Corporation
    Inventors: Sanjay Raghunath Deshpande, Tina Shui Wan Chan
  • Patent number: 5763159
    Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: June 9, 1998
    Assignee: Common Services Agency
    Inventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap